The 6 analysts offering 12-month price forecasts for Collegium Pharmaceutical Inc have a median target of 33.00, with a high estimate of 40.00 and a low estimate of 29.00. The median estimate represents a +32.32% increase from the last price of 24.94.
The current consensus among 8 polled investment analysts is to Buy stock in Collegium Pharmaceutical Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.96
Reporting Date Aug 05
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.